Anna Hoffmann

724 total citations
38 papers, 421 citations indexed

About

Anna Hoffmann is a scholar working on Cancer Research, Pharmacology and Hematology. According to data from OpenAlex, Anna Hoffmann has authored 38 papers receiving a total of 421 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cancer Research, 6 papers in Pharmacology and 6 papers in Hematology. Recurrent topics in Anna Hoffmann's work include Protease and Inhibitor Mechanisms (7 papers), Pharmacogenetics and Drug Metabolism (5 papers) and Blood Coagulation and Thrombosis Mechanisms (4 papers). Anna Hoffmann is often cited by papers focused on Protease and Inhibitor Mechanisms (7 papers), Pharmacogenetics and Drug Metabolism (5 papers) and Blood Coagulation and Thrombosis Mechanisms (4 papers). Anna Hoffmann collaborates with scholars based in Germany, Czechia and France. Anna Hoffmann's co-authors include F Markwárdt, Juergen Siepmann, Brian Carlin, F. Siepmann, B. Leclercq, H.‐P. Klöcking, B Terhaag, Holger H. Sigusch, Marion Hippius and Werner Siegmund and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Journal of Controlled Release.

In The Last Decade

Anna Hoffmann

36 papers receiving 393 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anna Hoffmann Germany	13	90	89	84	63	58	38	421
Mariët Ouwehand Netherlands	11	84 0.9×	70 0.8×	266 3.2×	121 1.9×	79 1.4×	16	506
Kunio Nakanishi Japan	11	41 0.5×	124 1.4×	67 0.8×	82 1.3×	42 0.7×	37	342
Jithan Aukunuru India	14	44 0.5×	201 2.3×	52 0.6×	144 2.3×	24 0.4×	45	528
Asako Nishimura Japan	13	56 0.6×	36 0.4×	134 1.6×	72 1.1×	72 1.2×	30	414
Akira Yanagawa Japan	12	16 0.2×	86 1.0×	40 0.5×	98 1.6×	17 0.3×	37	489
B. A. John United States	11	41 0.5×	26 0.3×	39 0.5×	113 1.8×	28 0.5×	19	446
Hirokazu Katayama Japan	12	39 0.4×	84 0.9×	44 0.5×	109 1.7×	44 0.8×	30	398
Jyoti Wadhwa India	12	21 0.2×	146 1.6×	22 0.3×	75 1.2×	10 0.2×	26	453
Luka Peternel Slovenia	11	11 0.1×	123 1.4×	47 0.6×	100 1.6×	20 0.3×	21	376
Diane Tang‐Liu United States	15	41 0.5×	192 2.2×	72 0.9×	163 2.6×	32 0.6×	34	826

Countries citing papers authored by Anna Hoffmann

Since Specialization

Citations

This map shows the geographic impact of Anna Hoffmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Hoffmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Hoffmann more than expected).

Fields of papers citing papers by Anna Hoffmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Hoffmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Hoffmann. The network helps show where Anna Hoffmann may publish in the future.

Co-authorship network of co-authors of Anna Hoffmann

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Hoffmann. A scholar is included among the top collaborators of Anna Hoffmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Hoffmann. Anna Hoffmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Couttas, Timothy A., Franziska Pahlisch, Juliane K. Mueller, et al.. (2024). Dose-dependent effects of oral cannabidiol and delta-9-tetrahydrocannabinol on serum anandamide and related N-acylethanolamines in healthy volunteers. SHILAP Revista de lepidopterología. 27(1). e301027–e301027.

Rohleder, Cathrin, et al.. (2024). Alterations to sphingolipid metabolism from antipsychotic administration in healthy volunteers are restored following the use of cannabidiol. Psychiatry Research. 339. 116005–116005. 3 indexed citations

Wagener, Rabea, Ute Fischer, Anna Hoffmann, et al.. (2024). Hyperdiploid acute lymphoblastic leukemia in children with LZTR1 germline variants. HemaSphere. 8(1). e26–e26. 2 indexed citations

Guennewig, Boris, Anna Hoffmann, Cathrin Rohleder, et al.. (2024). ReTimeML: a retention time predictor that supports the LC–MS/MS analysis of sphingolipids. Scientific Reports. 14(1). 4375–4375. 2 indexed citations

Siegmund, Werner, Georg Engel, M Zschiesche, et al.. (2003). Variability of Intestinal Expression of P-Glycoprotein in Healthy Volunteers as Described by Absorption of Talinolol from Four Bioequivalent Tablets. Journal of Pharmaceutical Sciences. 92(3). 604–610. 30 indexed citations

Zschiesche, M, B Terhaag, Anna Hoffmann, et al.. (2002). Stereoselective disposition of talinolol in man. Journal of Pharmaceutical Sciences. 91(2). 303–311. 26 indexed citations

Hippius, Marion, et al.. (2002). Assessment of ADRs associated with lipid- lowering agents recorded in the Department of Internal Medicine, University Hospital, Jena. International Journal of Clinical Pharmacology and Therapeutics. 40(3). 97–101. 3 indexed citations

Terhaag, B, et al.. (2000). Bioavailability of a new effervescent tablet of diclofenac. International Journal of Clinical Pharmacology and Therapeutics. 38(11). 546–551. 18 indexed citations

Hippius, Marion, et al.. (1998). In vitro investigations of drug release and penetration — enhancing effect of ultrasound on transmembrane transport of flufenamic acid. Experimental and Toxicologic Pathology. 50(4-6). 450–452. 12 indexed citations

10.

Hippius, Marion, et al.. (1998). In vitro investigations of drug release and penetration--enhancing effect of ultrasound on transmembrane transport of flufenamic acid.. PubMed. 36(2). 107–11. 13 indexed citations

11.

Klöcking, H.‐P., Anna Hoffmann, & Jawed Fareed. (1991). Influence of Hypersulfated Lactobionic Acid Amides on Tissue Plasminogen Activator Release. Seminars in Thrombosis and Hemostasis. 17(4). 379–384. 5 indexed citations

12.

Hoffmann, Anna, et al.. (1991). Influence of synthetic sulfated bis-lactobionic acid amides on tissue-type plasminogen activator release. Thrombosis Research. 62(3). 227–230. 3 indexed citations

13.

Brix, Rikke, et al.. (1991). [The bioequivalence of doxycycline in two preparations in capsule form].. PubMed. 41(12). 1289–93. 3 indexed citations

14.

Klöcking, H.‐P. & Anna Hoffmann. (1990). Inhibition of thrombin-induced tissue-type plasminogen activator release by agents which increase intracellular cyclic AMP. Thrombosis Research. 59(4). 789–792. 4 indexed citations

15.

Hoffmann, Anna, et al.. (1990). Acute release of plasminogen activator by ethyl alcohol in the isolated perfused pig ear.. PubMed. 45(5). 378–9. 2 indexed citations

16.

Klöcking, H.‐P., Anna Hoffmann, & F Markwárdt. (1988). Influence of α-NAPAP on thrombin-induced release of plasminogen activator. Thrombosis Research. 52(1). 71–73. 1 indexed citations

17.

Hoffmann, Anna, et al.. (1988). Influence of hirudin on the thrombin-induced release of tissue plasminogen activator from isolated perfused pig ear.. PubMed. 115(1-2). 110–2. 2 indexed citations

18.

Markwárdt, F, Anna Hoffmann, & Jörg Stürzebecher. (1983). Influence of Thrombin Inhibitors on the Thrombin-Induced Activation of Human Blood Platelets. Pathophysiology of Haemostasis and Thrombosis. 13(4). 227–233. 19 indexed citations

19.

Hoffmann, Anna, et al.. (1978). Inhibition of adrenaline-potentiated thrombin-induced reaction of human blood platelets by dihydroergotoxine.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 37(7). 1073–9. 1 indexed citations

20.

Markwárdt, F & Anna Hoffmann. (1970). Effects of papaverine derivatives on cyclic AMP phosphodiesterase of human platelets. Biochemical Pharmacology. 19(8). 2519–2520. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact